15 November 2020 - Performing on stage, going to university and surfing are things Andrew Scott never thought he would be able to do.
But since taking emicizumab, a cutting-edge preventative treatment for people with severe haemophilia, he can now live what he calls “a relatively normal life”.
“I thought it was too rare to be cured,” the 20-year-old said. “I was in a really helpless place.”